{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:58:54Z","timestamp":1787774334342,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-022-02389-4","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T22:02:50Z","timestamp":1661378570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Lipid- and TPGS-Based Core\u2013Shell-Type Nanocapsules Endowed with High Paclitaxel Loading and Enhanced Anticancer Potential"],"prefix":"10.1208","volume":"23","author":[{"given":"Sameer S.","family":"Katiyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Ghadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Kuche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Kushwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chander Parkash","family":"Dora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0688-9563","authenticated-orcid":false,"given":"Sanyog","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"2389_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/nnm-2018-0138","volume":"14","author":"MD Rege","year":"2019","unstructured":"Rege MD, Ghadi R, Katiyar SS, Kushwah V, Jain S. Exploring an interesting dual functionality of anacardic acid for efficient paclitaxel delivery in breast cancer therapy. Nanomedicine Future Medicine. 2019;14:57\u201375.","journal-title":"Nanomedicine Future Medicine"},{"key":"2389_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jconrel.2020.12.012","volume":"330","author":"N Malavia","year":"2021","unstructured":"Malavia N, Kuche K, Ghadi R, Jain S. A bird\u2019s eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer. J Control Release. 2021;330:72\u2013100.","journal-title":"J Control Release"},{"key":"2389_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jconrel.2017.01.014","volume":"248","author":"R Ghadi","year":"2017","unstructured":"Ghadi R, Dand N. BCS class IV drugs: Highly notorious candidates for formulation development. J Control Release. 2017;248:71\u201395.","journal-title":"J Control Release"},{"key":"2389_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","volume":"108","author":"JI Hare","year":"2017","unstructured":"Hare JI, Lammers T, Ashford MB, Puri S, Storm G, Barry ST. Challenges and strategies in anti-cancer nanomedicine development: an industry perspective. Adv Drug Deliv Rev. 2017;108:25\u201338.","journal-title":"Adv Drug Deliv Rev"},{"key":"2389_CR5","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1021\/acsbiomaterials.0c01290","volume":"6","author":"SS Katiyar","year":"2020","unstructured":"Katiyar SS, Ghadi R, Kushwah V, Dora CP, Jain S. Lipid and biosurfactant based core\u2013shell-type nanocapsules having high drug loading of paclitaxel for improved breast cancer therapy. ACS Biomater Sci Eng Am Chem Soc. 2020;6:6760\u20139.","journal-title":"ACS Biomater Sci Eng Am Chem Soc"},{"key":"2389_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.colsurfb.2016.11.002","volume":"150","author":"J Kim","year":"2017","unstructured":"Kim J, Ramasamy T, Choi JY, Kim ST, Youn YS, Choi H-G, et al. PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer. Colloids Surf, B. 2017;150:393\u2013401.","journal-title":"Colloids Surf, B"},{"key":"2389_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijpharm.2018.12.043","volume":"557","author":"SS Katiyar","year":"2019","unstructured":"Katiyar SS, Kushwah V, Dora CP, Jain S. Novel biosurfactant and lipid core-shell type nanocapsular sustained release system for intravenous application of methotrexate. Int J Pharm. 2019;557:86\u201396.","journal-title":"Int J Pharm"},{"key":"2389_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7150\/thno.22711","volume":"8","author":"C Yang","year":"2018","unstructured":"Yang C, Wu T, Qi Y, Zhang Z. Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics. 2018;8:464\u201385.","journal-title":"Theranostics"},{"key":"2389_CR9","doi-asserted-by":"publisher","first-page":"14495","DOI":"10.1002\/ange.201908357","volume":"131","author":"G Yang","year":"2019","unstructured":"Yang G, Liu Y, Wang H, Wilson R, Hui Y, Yu L, et al. Bioinspired core\u2013shell nanoparticles for hydrophobic drug delivery. Angew Chem. 2019;131:14495\u2013502.","journal-title":"Angew Chem"},{"key":"2389_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11051-020-04990-9","volume":"22","author":"N Behdarvand","year":"2020","unstructured":"Behdarvand N, Bikhof Torbati M, Shaabanzadeh M. Tamoxifen-loaded PLA\/DPPE-PEG lipid-polymeric nanocapsules for inhibiting the growth of estrogen-positive human breast cancer cells through cell cycle arrest. J Nanopart Res. 2020;22:262.","journal-title":"J Nanopart Res"},{"key":"2389_CR11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.2174\/1389450121666200611140425","volume":"22","author":"DP Wande","year":"2021","unstructured":"Wande DP, Cui Q, Chen S, Xu C, Xiong H, Yao J. Rediscovering tocophersolan: a renaissance for nano-based drug delivery and nanotheranostic applications. Curr Drug Targets. 2021;22:856\u201369.","journal-title":"Curr Drug Targets"},{"key":"2389_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.canlet.2013.04.020","volume":"336","author":"J Tang","year":"2013","unstructured":"Tang J, Fu Q, Wang Y, Racette K, Wang D, Liu F. Vitamin E reverses multidrug resistance in vitro and in vivo. Cancer Lett. 2013;336:149\u201357.","journal-title":"Cancer Lett"},{"key":"2389_CR13","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1016\/j.biomaterials.2012.03.046","volume":"33","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Tan S, Feng S-S. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials. 2012;33:4889\u2013906.","journal-title":"Biomaterials"},{"key":"2389_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ijpharm.2019.02.013","volume":"560","author":"P Bapat","year":"2019","unstructured":"Bapat P, Ghadi R, Chaudhari D, Katiyar SS, Jain S. Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin. Int J Pharm. 2019;560:219\u201327.","journal-title":"Int J Pharm"},{"key":"2389_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijpharm.2016.10.029","volume":"515","author":"D Zhao","year":"2016","unstructured":"Zhao D, Zhang H, Yang S, He W, Luan Y. Redox-sensitive mPEG-SS-PTX\/TPGS mixed micelles: an efficient drug delivery system for overcoming multidrug resistance. Int J Pharm. 2016;515:281\u201392.","journal-title":"Int J Pharm"},{"key":"2389_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2147\/DDDT.S127328","volume":"11","author":"Y Su","year":"2017","unstructured":"Su Y, Hu J, Huang Z, Huang Y, Peng B, Xie N, et al. Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance. DDDT Dove Press. 2017;11:659\u201368.","journal-title":"DDDT Dove Press"},{"key":"2389_CR17","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.msec.2018.05.054","volume":"91","author":"B Gorain","year":"2018","unstructured":"Gorain B, Choudhury H, Pandey M, Kesharwani P. Paclitaxel loaded vitamin E-TPGS nanoparticles for cancer therapy. Mater Sci Eng, C. 2018;91:868\u201380.","journal-title":"Mater Sci Eng, C"},{"key":"2389_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/1061186X.2017.1298603","volume":"25","author":"S Jain","year":"2017","unstructured":"Jain S, Garg T, Kushwah V, Thanki K, Agrawal AK, Dora CP. \u03b1-Tocopherol as functional excipient for resveratrol and coenzyme Q10-loaded SNEDDS for improved bioavailability and prophylaxis of breast cancer. J Drug Targeting. 2017;25:554\u201365 (Taylor & Francis).","journal-title":"J Drug Targeting"},{"key":"2389_CR19","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.nano.2018.04.009","volume":"14","author":"V Kushwah","year":"2018","unstructured":"Kushwah V, Katiyar SS, Agrawal AK, Gupta RC, Jain S. Co-delivery of docetaxel and gemcitabine using PEGylated self-assembled stealth nanoparticles for improved breast cancer therapy. Nanomedicine: Nanotechnol Biol Med. 2018;14:1629\u201341.","journal-title":"Nanomedicine: Nanotechnol Biol Med"},{"key":"2389_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.actbio.2018.03.057","volume":"73","author":"V Kushwah","year":"2018","unstructured":"Kushwah V, Katiyar SS, Dora CP, Kumar Agrawal A, Lamprou DA, Gupta RC, et al. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management. Acta Biomater. 2018;73:424\u201336.","journal-title":"Acta Biomater"},{"key":"2389_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12:263\u201371.","journal-title":"AAPS J"},{"key":"2389_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.biopha.2017.05.069","volume":"92","author":"KC Karnam","year":"2017","unstructured":"Karnam KC, Ellutla M, Bodduluru LN, Kasala ER, Uppulapu SK, Kalyankumarraju M, et al. Preventive effect of berberine against DMBA-induced breast cancer in female Sprague Dawley rats. Biomed Pharmacother. 2017;92:207\u201314.","journal-title":"Biomed Pharmacother"},{"key":"2389_CR23","doi-asserted-by":"publisher","first-page":"102809","DOI":"10.1016\/j.jddst.2021.102809","volume":"66","author":"MK Prajapati","year":"2021","unstructured":"Prajapati MK, Pai R, Vavia P. Tuning ligand number to enhance selectivity of paclitaxel liposomes towards ovarian cancer. J Drug Deliver Sci Technol. 2021;66:102809.","journal-title":"J Drug Deliver Sci Technol"},{"key":"2389_CR24","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","volume":"98","author":"D Kalyane","year":"2019","unstructured":"Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia K, Tekade RK. Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng, C. 2019;98:1252\u201376.","journal-title":"Mater Sci Eng, C"},{"key":"2389_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0169-409X(95)00026-4","volume":"16","author":"R Gref","year":"1995","unstructured":"Gref R, Domb A, Quellec P, Blunk T, M\u00fcller RH, Verbavatz JM, et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev. 1995;16:215\u201333.","journal-title":"Adv Drug Deliv Rev"},{"key":"2389_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","volume":"5","author":"PL Ritger","year":"1987","unstructured":"Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Controlled Release. 1987;5:37\u201342.","journal-title":"J Controlled Release."},{"key":"2389_CR27","unstructured":"Receptor-mediated endocytosis of nanoparticles of various shapes | Nano Letters [Internet]. [cited 2022 Jun 9]. Available from: https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/nl2030213"},{"key":"2389_CR28","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1016\/j.biomaterials.2012.01.036","volume":"33","author":"MS Muthu","year":"2012","unstructured":"Muthu MS, Kulkarni SA, Raju A, Feng S-S. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials. 2012;33:3494\u2013501.","journal-title":"Biomaterials"},{"key":"2389_CR29","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1007\/s11095-012-0958-3","volume":"30","author":"SA Kulkarni","year":"2013","unstructured":"Kulkarni SA, Feng S-S. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res. 2013;30:2512\u201322.","journal-title":"Pharm Res"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-022-02389-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T16:06:52Z","timestamp":1666714012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-022-02389-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["2389"],"URL":"https:\/\/doi.org\/10.1208\/s12249-022-02389-4","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"238"}}